Note: 10X Genomics's revenues are gauged from an analysis of company filings.
10X Genomics's Income Statement (based on Industry Averages)
10X Genomics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
10X Genomics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 9, 2019
0
N/A
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that 10X Genomics is developing and marketing.
10X Genomics doesn't have any recent trademark applications, indicating 10X Genomics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
VISIUM reagent-treated slides having arrays for biological analysis for medical research and scientific research purposes; kits for medical research and scientific research purposes that are comprised of a slide having an array for biological analysis, an adaptor, a slide alignment tool and a magnetic separator; laboratory equipment, namely, devices for preparation and analysis of biological samples using reagent-treated slides and chemical reagents
01/22/2021
SPATIAL TRANSCRIPTOMICS chemical reagents provided on glass slides for use in scientific research
02/25/2019
10X SPATIAL TRANSCRIPTOMICS DNA chips; scientific research and laboratory apparatus; computer software
02/25/2019
See all trademarks and details in the Full Report.
Market Share of 10X Genomics's Largest Competitors
A competitive analysis shows these companies are in the same general field as 10X Genomics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to 10X Genomics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as 10X Genomics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.